Evidence map›Paper›PMID 28043942›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2017

A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study.

Kumar B Rajan, Robert S Wilson, Lisa L Barnes, Neelum T Aggarwal, Jennifer Weuve, Denis A Evans

Abstract readComparative Study
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A Bayesian hierarchical change point model with parameter constraints.Statistical methods in medical research · 2021
    Article
  5. Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018
    Article
  6. Terminal decline of episodic memory and perceptual speed in a biracial population.Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2018
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kumar B RajanDepartment of Internal Medicine, Rush Institute for Healthy Aging.
Robert S WilsonRush Alzheimer's Disease Center.
Lisa L BarnesRush Alzheimer's Disease Center.
Neelum T AggarwalRush Alzheimer's Disease Center.
Jennifer WeuveDepartment of Internal Medicine, Rush Institute for Healthy Aging.
Denis A EvansDepartment of Internal Medicine, Rush Institute for Healthy Aging.

Funding

Nonlinear Models of Cognition Preceding AD in a Biracial Population SampleR01AG051635 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAJAN, KUMAR B. · 2016 to 2020
$1.5M
NIA NIH HHS R01 AG051635
6 · The paper itself

Abstract

Background: Cognitive changes during the preclinical phase of Alzheimer's disease (AD) dementia have been characterized among European Americans (EAs), but studies of preclinical changes among African Americans (AAs) are notably absent. Methods: Preclinical changes in cognition before the development of AD dementia and mild cognitive impairment over a period of 18 years were examined using change points in a biracial sample of 2,125 older adults. Results: Of 2,125 participants, 442 (21%) developed AD dementia and 661 (31%) developed mild cognitive impairment. A cognitive change point occurred between 4 and 5 years before the clinical diagnosis of AD dementia. Differences between AAs and EAs were observed: EAs had a higher starting level of composite cognitive function, and a change point occurred 4.3 years before AD dementia among AAs and 4.7 years among EAs. The slope of cognitive decline after the change point among those developing clinical AD dementia was significantly greater among EAs (0.233 units/y) than among AAs (0.171 units/y; p < .001). This difference in slope of cognitive decline persisted after diagnosis of AD dementia so that at the conclusion of observation the difference in average cognitive level was reversed. AAs without cognitive impairment had a lower average baseline of cognition than EAs, but the slopes of cognitive decline were similar. Conclusions: A prominent change to a steeper slope of cognitive decline occurs between 4 and 5 years prior to the diagnosis of AD dementia. The slope of cognitive decline after the change point is steeper among EAs than AAs.

Indexed as

Black or African AmericanWhite PeopleAgedAlzheimer DiseaseCognitive DysfunctionDementiaFemaleHumansMaleAlzheimer’s diseaseCognitive changeMild cognitive impairment

Identifiers

PMID28043942
PMCPMC5965301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.